Supplementary Tables 1-6 from Uterine Lavage Identifies Cancer Mutations and Increased <i>TP53</i> Somatic Mutation Burden in Individuals with Ovarian Cancer
Talayeh Ghezelayagh(University of Washington), Rosa Ana Risques(University of Washington), Jennifer K. Burzawa, Barbara M. Norquist(University of Washington), Enna Manhardt(University of Washington), Renata R. Urban(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Heidi J. Gray(Seattle Cancer Care Alliance), John B. Liao(Seattle Pacific University), Barbara A. Goff(University of Washington), Marc R. Radke(University of Washington), Kemi M. Doll(University of Washington), Brendan F. Kohrn(University of Washington), Elizabeth M. Swisher(University of Washington), Kathryn P. Pennington(University of Washington), P Speiser(Medical University of Vienna), Elise J. Simons(University of Washington), Jeanne Fredrickson(University of Washington), Ronit Katz(University of Washington)
Cited by 0
Related Papers
Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
|New England Journal of Medicine|2013|968
Telomere-to-telomere assembly of a complete human X chromosome
|Nature|2020|842
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
Multiple loci associated with indices of renal function and chronic kidney disease
|Nature Genetics|2009|658
Genetic/Familial High-Risk Assessment: Breast and Ovarian
|Journal of the National Comprehensive Cancer Network|2010|650